Von Willebrand disease is a common inherited bleeding disorder that affects how blood clots, caused by problems with a protein that helps platelets stick together and carry another clotting protein through the bloodstream. Recognizing when to seek testing and understanding the diagnostic process can help people get the right care and manage bleeding episodes more effectively.

Introduction: Who Should Seek Diagnostics

Diagnosing von Willebrand disease can be challenging because many people with the condition experience only mild symptoms that might go unnoticed for years. Some individuals live with the disorder without ever knowing they have it, while others discover it only when unusual bleeding occurs after surgery, dental work, or childbirth.^[1]

You should consider seeking diagnostic testing if you notice patterns of bleeding that seem different from what most people experience. This includes frequent nosebleeds that last longer than ten minutes, easy bruising that creates large or raised marks, bleeding from cuts that continues for more than ten minutes, or heavy menstrual periods that disrupt your daily life.^[2] Women often notice symptoms during their menstrual periods, when bleeding may be so heavy that pads or tampons need changing every hour, or bleeding lasts longer than seven days.^[3]

Family history plays an important role in deciding when to pursue testing. If your parent, child, brother, or sister has been diagnosed with von Willebrand disease, you should speak with your healthcare provider about testing even if you don’t have obvious symptoms. Since this is an inherited condition, it can be passed down through families, and some people carry the genetic changes without experiencing significant bleeding problems.^[5]

Heavy bleeding after surgical procedures, including dental surgery, or after giving birth or having a miscarriage are strong signals that diagnostic testing may be needed. Blood appearing in your urine or stool should also prompt a conversation with your healthcare provider about possible bleeding disorders.^[2] Even if these symptoms seem minor or infrequent, documenting them and discussing them with a doctor can help determine whether further evaluation is necessary.

Women who experience heavy or prolonged bleeding during menstrual periods, particularly if they develop iron-deficiency anemia (a condition where your body doesn’t have enough iron to make hemoglobin, the substance in red blood cells that carries oxygen), should seek evaluation. This type of anemia can develop from chronic blood loss and may be the first clue that an underlying bleeding disorder exists.^[2]

Classic Diagnostic Methods

The diagnosis of von Willebrand disease requires multiple steps and cannot be confirmed with just one test. Your healthcare provider will begin with a thorough review of your personal and family bleeding history. They’ll ask detailed questions about how often you bleed, how long bleeding lasts, and whether other family members have similar experiences.^[9] This conversation helps establish whether your bleeding pattern suggests a disorder rather than isolated incidents.

A physical examination follows the history-taking, during which your doctor will look for signs of recent bleeding such as bruises or other visible marks on your skin. However, the physical exam alone cannot confirm the diagnosis, as many people with von Willebrand disease appear completely normal between bleeding episodes.^[9]

Blood tests form the core of the diagnostic process for von Willebrand disease. These tests need to be performed in a specialized center that has the capability and experience to conduct and interpret the specific assays required. The main blood tests used to diagnose this condition measure different aspects of von Willebrand factor in your bloodstream.^[12]

The first key test measures von Willebrand factor antigen, which shows the level or amount of von Willebrand factor present in your blood. This test essentially counts how much of this protein is floating in your plasma by measuring a certain protein marker.^[9] People with Type 1 von Willebrand disease typically have lower than normal amounts of this protein, while those with Type 2 may have normal amounts but the protein doesn’t work properly.

Another essential test measures von Willebrand factor activity, which evaluates how well the von Willebrand factor actually performs its job in the clotting process. This test is different from simply measuring the amount of protein because having enough von Willebrand factor doesn’t guarantee it works correctly. Some people have plenty of the protein, but it’s structured wrong and can’t help form clots effectively.^[9]

Factor VIII clotting activity must also be tested because von Willebrand factor serves as a carrier for another clotting protein called factor VIII, protecting it from breaking down too quickly in the bloodstream. This test shows whether your levels and activity of factor VIII are too low. When von Willebrand factor is deficient or doesn’t work properly, factor VIII levels often drop as well, which worsens bleeding problems.^[9]

A more specialized test called von Willebrand factor multimers analysis examines the structure and size of von Willebrand factor molecules in your blood. This test checks the form of von Willebrand factor and how its protein chains break down. It’s particularly important for determining which type of von Willebrand disease you have, as different types show different patterns in how these protein chains are organized.^[9]

One challenge with these blood tests is that results can change in the same person over time. Factors such as aging, stress, exercise, infection, pregnancy, and certain medicines can all affect von Willebrand factor levels and function. Because of this variability, you may need to repeat some tests on different days to get accurate results and confirm the diagnosis.^[9]

Blood type also influences von Willebrand factor levels. People with Type O blood naturally have lower levels of von Willebrand factor compared to people with other blood types, which can make diagnosis more complicated. Your doctor needs to consider your blood type when interpreting test results.^[4]

The diagnosis becomes easier when von Willebrand factor levels are severely reduced, as in Type 3 von Willebrand disease, the most serious form where the protein is virtually absent from the blood. However, in mild cases or situations where test results fall in borderline ranges, healthcare providers must carefully weigh whether pursuing a definite diagnosis serves the patient’s best interest or risks creating unnecessary anxiety and over-medicalization.^[12]

If your healthcare provider suspects you have von Willebrand disease based on initial testing, they will likely refer you to a hematologist, a doctor who specializes in blood conditions. Hematologists have expertise in interpreting the complex pattern of test results and determining which type of von Willebrand disease you have. They can also distinguish von Willebrand disease from other bleeding disorders, such as hemophilia, which has some similarities but requires different treatment approaches.^[9]

Diagnostics for Clinical Trial Qualification

When individuals with von Willebrand disease consider participating in clinical trials, additional or more detailed diagnostic testing may be required beyond what was needed for initial diagnosis. Clinical trials test new treatments or approaches, and researchers need very specific information about each participant’s condition to ensure safety and measure how well the treatment works.

The exact diagnostic criteria for enrolling in a clinical trial depend on what the study is investigating. Trials may specify which type of von Willebrand disease participants must have, such as only accepting people with Type 1, Type 3, or specific subtypes of Type 2. This means comprehensive testing to determine the exact type and subtype becomes essential for trial qualification, not just confirming that von Willebrand disease is present.^[4]

Some clinical trials may require baseline measurements of bleeding frequency. Participants might need to track and document all bleeding episodes for a period of time before enrolling to establish how often bleeds occur naturally without the experimental treatment. This helps researchers compare bleeding patterns before and after treatment begins.

Blood tests measuring specific levels of von Willebrand factor antigen and activity serve as standard criteria for many trials. Researchers often set minimum or maximum threshold levels that participants must meet. For example, a trial testing a treatment for severe disease might only accept people whose von Willebrand factor levels fall below a certain point, while a study focused on mild to moderate disease would set different criteria.^[12]

For trials evaluating treatments like desmopressin, participants may need to undergo a test infusion before enrollment. During this test, doctors give a dose of the medication when the person is not actively bleeding, then measure how much the von Willebrand factor level rises in response. This determines whether someone’s body responds to the medication or not. People who don’t respond well wouldn’t be appropriate for trials testing desmopressin-based treatments.^[9]

Factor VIII activity levels may also need to be measured and documented for trial qualification. Since von Willebrand factor carries factor VIII in the bloodstream, researchers studying new von Willebrand factor replacement therapies want to understand both proteins’ levels before treatment starts. This provides baseline data for comparison as the trial progresses.^[4]

Clinical trials may require testing for inhibitors, which are antibodies that the immune system sometimes develops against clotting factors. People with inhibitors typically need different treatments, and their presence could affect how well an experimental therapy works. Testing for these antibodies ensures that trial participants don’t have complications that would make them unsuitable for the study.^[13]

Some studies focus specifically on women with heavy menstrual bleeding related to von Willebrand disease. For these trials, detailed documentation of menstrual patterns, including duration and heaviness of bleeding, frequency of pad or tampon changes, and presence of blood clots in menstrual flow, may be required during a screening period before enrollment can occur.^[3]

Pregnancy status must be confirmed for women of childbearing age considering trial participation, as some experimental treatments might not be safe during pregnancy. Blood or urine pregnancy tests are standard requirements, and trials may require participants to use specific contraception methods during the study period to avoid pregnancy while taking experimental medications.^[9]